ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Yue Qing

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 6 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

CLDN18.2 CAR-derived Extracellular Vesicle Immunotherapy Improves Outcome in Murine Pancreatic Cancer. Co-author DOI 10.1002/adhm.202500546 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yaru Zhao · 1 shared paper, 2025 · strength 0.27
- Paper CLDN18.2 CAR-derived Extracellular Vesicle Immunotherapy Improves Outcome in Murine Pancreatic Cancer. DOI 10.1002/adhm.202500546 ↗
Hua Jiang · 1 shared paper, 2025 · strength 0.27
- Paper CLDN18.2 CAR-derived Extracellular Vesicle Immunotherapy Improves Outcome in Murine Pancreatic Cancer. DOI 10.1002/adhm.202500546 ↗
Zonghai Li · 1 shared paper, 2025 · strength 0.27
- Paper CLDN18.2 CAR-derived Extracellular Vesicle Immunotherapy Improves Outcome in Murine Pancreatic Cancer. DOI 10.1002/adhm.202500546 ↗
Christopher Heeschen · 1 shared paper, 2025 · strength 0.27
- Paper CLDN18.2 CAR-derived Extracellular Vesicle Immunotherapy Improves Outcome in Murine Pancreatic Cancer. DOI 10.1002/adhm.202500546 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.